Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
      EC 2.4.1
      EC 2.4.2
        EC 2.4.2.1
        EC 2.4.2.2
        EC 2.4.2.3
        EC 2.4.2.4
        EC 2.4.2.5
        EC 2.4.2.6
        EC 2.4.2.7
        EC 2.4.2.8
        EC 2.4.2.9
        EC 2.4.2.10
        EC 2.4.2.11
        EC 2.4.2.12
        EC 2.4.2.13
        EC 2.4.2.14
        EC 2.4.2.15
        EC 2.4.2.16
        EC 2.4.2.17
        EC 2.4.2.18
        EC 2.4.2.19
        EC 2.4.2.20
        EC 2.4.2.21
        EC 2.4.2.22
        EC 2.4.2.23
        EC 2.4.2.24
        EC 2.4.2.25
        EC 2.4.2.26
        EC 2.4.2.27
        EC 2.4.2.28
        EC 2.4.2.29
        EC 2.4.2.30
        EC 2.4.2.31
        EC 2.4.2.32
        EC 2.4.2.33
        EC 2.4.2.34
        EC 2.4.2.35
        EC 2.4.2.36
        EC 2.4.2.37
        EC 2.4.2.38
        EC 2.4.2.39
        EC 2.4.2.40
      EC 2.4.99
    EC 2.5
    EC 2.6
    EC 2.7
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.4.2.30 - NAD + :poly(adenosine- diphosphate- D- ribosyl) - acceptor ADP- D- ribosyl- transferase (NAD + ADP- ribosyltransferase)



3D structures of EC 2.4.2.30 - NAD+ ADP-ribosyltransferase in Protein Data Bank

updated: 26 February 2021, 5:15

In total: 376 PDB structures of EC 2.4.2.30 - NAD+ ADP-ribosyltransferase:
  1. 1a26: The Catalytic Fragment of Poly(adp-ribose) Polymerase Complexed with Carba-nad
  2. 1efy: Crystal Structure of The Catalytic Fragment of Poly (adp- Ribose) Polymerase Complexed with a Benzimidazole Inhibitor
  3. 1gs0: Crystal Structure of The Catalytic Fragment of Murine Poly (adp-ribose) Polymerase-2
  4. 4pax: The Catalytic Fragment of Poly(adp-ribose) Polymerase Complexed with 8-hydroxy-2-methyl-3-hydro-quinazolin-4-one
  5. 3pax: The Catalytic Fragment of Poly(adp-ribose) Polymerase Complexed with 3-methoxybenzamide
  6. 3p0q: Human Tankyrase 2 - Catalytic Parp Domain in Complex with an Inhibitor
  7. 3p0p: Human Tankyrase 2 - Catalytic Parp Domain in Complex with an Inhibitor
  8. 3p0n: Human Tankyrase 2 - Catalytic Parp Domain in Complex with an Inhibitor
  9. 6ntu: Crystal Structure of Human Parp-1 Art Domain Bound to Inhibitor Uktt- 15
  10. 3mhk: Human Tankyrase 2 - Catalytic Parp Domain in Complex with 2-(2- Pyridyl)-7,8-dihydro-5h-thiino[4,3-d]pyrimidin-4-ol
  11. 3mhj: Human Tankyrase 2 - Catalytic Parp Domain in Complex with 1-methyl-3- (trifluoromethyl)-5h-benzo[c][1,8]naphtyridine-6-one
  12. 3l3m: Parp Complexed with A927929
  13. 3kr8: Human Tankyrase 2 - Catalytic Parp Domain in Complex with an Inhibitor Xav939
  14. 3kr7: Human Tankyrase 2 - Catalytic Parp Domain
  15. 3kjd: Human Poly(adp-ribose) Polymerase 2, Catalytic Fragment in Complex with an Inhibitor Abt-888
  16. 3kcz: Human Poly(adp-ribose) Polymerase 2, Catalytic Fragment in Complex with an Inhibitor 3-aminobenzamide
  17. 1pax: The Catalytic Fragment of Poly(adp-ribose) Polymerase Complexed with 3,4-dihydro-5-methyl-isoquinolinone
  18. 3hkv: Human Poly(adp-ribose) Polymerase 10, Catalytic Fragment in Complex with an Inhibitor 3-aminobenzamide
  19. 1qs1: Crystal Structure of Vegetative Insecticidal Protein2 (vip2)
  20. 1qs2: Crystal Structure of Vip2 with Nad
  21. 3goy: Crystal Structure of Human Poly(adp-ribose) Polymerase 14, Catalytic Fragment in Complex with an Inhibitor 3- Aminobenzamide
  22. 3gn7: Parp Complexed with A861696
  23. 3gjw: Parp Complexed with A968427
  24. 3gey: Crystal Structure of Human Poly(adp-ribose) Polymerase 15, Catalytic Fragment in Complex with an Inhibitor Pj34
  25. 3fhb: Human Poly(adp-ribose) Polymerase 3, Catalytic Fragment in Complex with an Inhibitor 3-aminobenzoic Acid
  26. 1uk0: Crystal Structure of Catalytic Domain of Human Poly(adp- Ribose) Polymerase with a Novel Inhibitor
  27. 1uk1: Crystal Structure of Human Poly(adp-ribose) Polymerase Complexed with a Potent Inhibitor
  28. 1uzi: C3 Exoenzyme from Clostridium Botulinum, Tetragonal Form
  29. 3ce0: Human Poly(adp-ribose) Polymerase 3, Catalytic Fragment in Complex with an Inhibitor Pj34
  30. 1v9x: Solution Structure of The First Zn-finger Domain of Poly(adp-ribose) Polymerase-1
  31. 3c4h: Human Poly(adp-ribose) Polymerase 3, Catalytic Fragment in Complex with an Inhibitor Dr2313
  32. 3c49: Human Poly(adp-ribose) Polymerase 3, Catalytic Fragment in Complex with an Inhibitor Ku0058948
  33. 3blj: Crystal Structure of Human Poly(adp-ribose) Polymerase 15, Catalytic Fragment
  34. 1wok: Crystal Structure of Catalytic Domain of Human Poly(adp- Ribose) Polymerase Complexed with a Quinoxaline-type Inhibitor
  35. 7cmw: Complex Structure of Parp1 Catalytic Domain with Pamiparib
  36. 6tx3: Hpf1 Bound to Catalytic Fragment of Parp2
  37. 2riq: Crystal Structure of The Third Zinc-binding Domain of Human Parp-1
  38. 2rf5: Crystal Structure of Human Tankyrase 1- Catalytic Parp Domain
  39. 2rd6: Parp Complexed with A861695
  40. 2rcw: Parp Complexed with A620223
  41. 2cok: Solution Structure of Brct Domain of Poly(adp-ribose) Polymerase-1
  42. 2cr9: Solution Structure of Wgr Domain of Poly(adp-ribose) Polymerase-1
  43. 2cs2: Solution Structure of The Second Zn-finger Domain of Poly(adp-ribose) Polymerase-1
  44. 2pqf: Human Poly(adp-ribose) Polymerase 12, Catalytic Fragment in Complex with an Inhibitor 3-aminobenzoic Acid
  45. 2pax: The Catalytic Fragment of Poly(adp-ribose) Polymerase Complexed with 4-amino-1,8-naphthalimide
  46. 2paw: The Catalytic Fragment of Poly(adp-ribose) Polymerase
  47. 2dmj: Solution Structure of The First Zf-parp Domain of Human Poly(adp-ribose)polymerase-1
  48. 6bhv: Human Parp-1 Bound to Nad+ Analog Benzamide Adenine Dinucleotide (bad)
  49. 6a84: Tankyrase-2 in Complex with Compound 15d
  50. 5zqr: Tankyrase-2 in Complex with Compound 40c
  51. 5zqq: Tankyrase-2 in Complex with Compound 52
  52. 5zqp: Tankyrase-2 in Complex with Compound 12
  53. 5zqo: Tankyrase-2 in Complex with Compound 1a
  54. 2eoc: Solution Structure of The Wgr Domain from Human Poly [adp- Ribose] Polymerase-3
  55. 2hw2: Crystal Structure of Rifampin Adp-ribosyl Transferase in Complex with Rifampin
  56. 6x0n: Bridging of Double-strand Dna Break Activates Parp2/hpf1 to Modify Chromatin
  57. 6x0m: Bridging of Double-strand Dna Break Activates Parp2/hpf1 to Modify Chromatin
  58. 6x0l: Bridging of Double-strand Dna Break Activates Parp2/hpf1 to Modify Chromatin
  59. 2jvn: Domain C of Human Parp-1
  60. 6usj: Structure of Two Nucleosomes Bridged by Human Parp2
  61. 6urq: Complex Structure of Human Poly-adp-ribosyltransferase Tnks1 Arc2-arc3 and P Antigen Family Member 4 (page4)
  62. 2l30: Human Parp-1 Zinc Finger 1
  63. 2l31: Human Parp-1 Zinc Finger 2
  64. 2y0i: Factor Inhibiting Hif-1 Alpha in Complex with Tankyrase-2 (tnks2) Fragment Peptide (21-mer)
  65. 6vkq: Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Eb-47
  66. 6vko: Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Uktt15
  67. 6vkk: Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib
  68. 3l3l: Parp Complexed with A906894
  69. 3od8: Human Parp-1 Zinc Finger 1 (zn1) Bound to Dna
  70. 3oda: Human Parp-1 Zinc Finger 1 (zn1) Bound to Dna
  71. 3odc: Human Parp-1 Zinc Finger 2 (zn2) Bound to Dna
  72. 3ode: Human Parp-1 Zinc Finger 2 (zn2) Bound to Dna
  73. 6xvw: Catalytic Domain of Human Parp-1 in Complex with The Inhibitor Mc2050
  74. 3q6z: Human Parp14 (artd8)-macro Domain 1 in Complex with Adenosine-5- Diphosphoribose
  75. 3q71: Human Parp14 (artd8) - Macro Domain 2 in Complex with Adenosine-5- Diphosphoribose
  76. 6kro: Tankyrase-2 in Complex with Rk-582
  77. 3se2: Human Poly(adp-ribose) Polymerase 14 (parp14/artd8) - Catalytic Domain in Complex with 6(5h)-phenanthridinone
  78. 3smi: Human Poly(adp-ribose) Polymerase 14 (parp14/artd8) - Catalytic Domain in Complex with a Quinazoline Inhibitor
  79. 3smj: Human Poly(adp-ribose) Polymerase 14 (parp14/artd8) - Catalytic Domain in Complex with a Pyrimidine-like Inhibitor
  80. 2le0: Parp Brct Domain
  81. 3u9h: Complex Structure of Human Tankyrase 2 with Nicotinamide
  82. 3twq: Crystal Structure of Arc4 from Human Tankyrase 2 (apo Form)
  83. 3twr: Crystal Structure of Arc4 from Human Tankyrase 2 in Complex with Peptide from Human 3bp2
  84. 3tws: Crystal Structure of Arc4 from Human Tankyrase 2 in Complex with Peptide from Human Terf1 (chimeric Peptide)
  85. 3twt: Crystal Structure of Arc4 from Human Tankyrase 2 in Complex with Peptide from Human Mcl1 (chimeric Peptide)
  86. 3twu: Crystal Structure of Arc4 from Human Tankyrase 2 in Complex with Peptide from Human Mcl1
  87. 3twv: Crystal Structure of Arc4 from Human Tankyrase 2 in Complex with Peptide from Human Numa1 (chimeric Peptide)
  88. 3tww: Crystal Structure of Arc4 from Human Tankyrase 2 in Complex with Peptide from Human Lnpep (chimeric Peptide)
  89. 3twx: Crystal Structure of Arc4 from Human Tankyrase 2 in Complex with Peptide from Human Fnbp1 (chimeric Peptide)
  90. 6qxu: Human Tnks1 in Complex with 6,8-difluoro-2-[4-(1-hydroxy-1-methyl- Ethyl)-phenyl]-3h-quinazolin-4-one
  91. 3v2b: Human Poly(adp-ribose) Polymerase 15 (artd7, Bal3), Macro Domain 2 in Complex with Adenosine-5-diphosphoribose
  92. 3utm: Crystal Structure of a Mouse Tankyrase-axin Complex
  93. 3u9y: Crystal Structure of Human Tankyrase 2 Catalytic Domain in Complex with Olaparib
  94. 3ua9: Crystal Structure of Human Tankyrase 2 in Complex with a Selective Inhibitor
  95. 3udd: Tankyrase-1 in Complex with Small Molecule Inhibitor
  96. 3uh2: Tankyrase-1 in Complexed with Pj34
  97. 3uh4: Tankyrase-1 Complexed with Nvp-xav939
  98. 4dvi: Crystal Structure of Tankyrase 1 with Iwr2
  99. 6nrj: Crystal Structure of Human Parp-1 Art Domain Bound to Inhibitor Utt93
  100. 6nri: Crystal Structure of Human Parp-1 Art Domain Bound to Inhibitor Utt83
  101. 6nrh: Crystal Structure of Human Parp-1 Art Domain Bound Inhibitor Utt63
  102. 6nrg: Crystal Structure of Human Parp-1 Art Domain Bound to Inhibitor Utt57
  103. 6nrf: Crystal Structure of Human Parp-1 Art Domain Bound to Inhibitor Utt103
  104. 4dqy: Structure of Human Parp-1 Bound to a Dna Double Strand Break
  105. 4av1: Crystal Structure of The Human Parp-1 Dna Binding Domain in Complex with Dna
  106. 4avu: Crystal Structure of Human Tankyrase 2 in Complex with 6(5h) -phenanthridinone
  107. 4avw: Crystal Structure of Human Tankyrase 2 in Complex with Tiq-a
  108. 4f0d: Human Artd15/parp16 in Complex with 3-aminobenzamide
  109. 4f0e: Human Adp-ribosyltransferase 7 (artd7/parp15), Catalytic Domain in Complex with Sto1102
  110. 4f1l: Human Artd8 (parp14, Bal2) - Catalytic Domain in Complex with Inhibitor A16(z)
  111. 4f1q: Human Artd8 (parp14, Bal2) - Catalytic Domain in Complex with A16(e)
  112. 6i8t: The Catalytic Fragment of Poly(adp-ribose) Polymerase Complexed with an Isoindolinone Inhibitor
  113. 6i8m: The Catalytic Fragment of Poly(adp-ribose) Polymerase Complexed with Isoindolinone Inhibitor
  114. 4hki: Tankyrase 2 in Complex with Flavone
  115. 4hkk: Complex Structure of Human Tankyrase 2 with Apigenin
  116. 4hkn: Complex Structure of Human Tankyrase 2 with Luteolin
  117. 4hl5: Complex Structure of Human Tankyrase 2 with 7-hydroxy -4'- Methoxyflavone
  118. 4hlf: Crystal Structure of Tankyrase 2 in Complex with 7,3',4'- Trihydroxyflavone
  119. 4hlg: Crystal Structure of Tankyrase 2 in Complex with 3'-hydroxyflavone
  120. 4hlh: Crystal Structure of Tankyrase 2 in Complex with 4'-fluoroflavone
  121. 4hlk: Crystal Structure of Tankyrase 2 in Complex with 4'-methylflavone
  122. 4hlm: Crystal Structure of Tankyrase 2 in Complex with 3',4'- Dihydroxyflavone
  123. 4hmh: Crystal Structure of Tankyrase 2 in Complex with 7,3-dihydroxyflavone
  124. 6hxs: Human Parp16 (artd15) in Complex with Carba-nad
  125. 6hxr: Human Parp16 (artd15) in Complex with Eb-47
  126. 4abk: Human Parp14 (artd8, Bal2) - Macro Domain 3 in Complex with Adenosine-5-diphosphoribose
  127. 4abl: Human Parp14 (artd8, Bal2) - Macro Domain 3
  128. 4i9i: Crystal Structure of Tankyrase 1 with Compound 4
  129. 3vfq: Human Parp14 (artd8, Bal2) - Macro Domains 1 and 2 in Complex with Adenosine-5-diphosphoribose
  130. 4d86: Human Parp14 (artd8, Bal2) - Macro Domains 1 and 2 in Complex with Adenosine-5-diphosphate
  131. 4hhy: Crystal Structure of Parp Catalytic Domain in Complex with Novel Inhibitors
  132. 4hhz: Crystal Structure of Parp Catalytic Domain in Complex with Novel Inhibitors
  133. 4hyf: Structural Basis and Sar for Od 270, a Lead Stage 1,2,4-triazole Based Specific Tankyrase1/2 Inhibitor
  134. 6ghk: Human Parp1 (artd1) - Catalytic Domain in Complex with Inhibitor Me0527
  135. 6g0w: Human Parp14 (artd8), Catalytic Fragment in Complex with Inhibitor Mcd72
  136. 6fzm: Human Parp14 (artd8), Catalytic Fragment in Complex with Inhibitor Itk6
  137. 6fym: Human Parp14 (artd8), Catalytic Fragment in Complex with Inhibitor Itk1
  138. 6fxi: Human Parp10 (artd10), Catalytic Fragment in Complex with 3- Aminobenzamide and Citrate
  139. 4k4e: Co-crystal Structure of Tnks1 with Compound 52 [n~2-(5-chloro-2- Methoxyphenyl)-n-[trans-4-(2-oxo-2,3-dihydro-1h-benzimidazol-1-yl) Cyclohexyl]glycinamide]
  140. 4k4f: Co-crystal Structure of Tnks1 with Compound 18 [4-[(4s)-5,5-dimethyl- 2-oxo-4-phenyl-1,3-oxazolidin-3-yl]-n-(quinolin-8-yl)benzamide]
  141. 4bfp: Crystal Structure of Human Tankyrase 2 in Complex with Wiki4
  142. 4gv0: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Me0355
  143. 4gv2: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Me0354
  144. 4gv4: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Me0328
  145. 4gv7: Human Artd1 (parp1) - Catalytic Domain in Complex with Inhibitor Me0328
  146. 4iue: Tankyrase in Complex with 7-(2-fluorophenyl)-4-methyl-1,2- Dihydroquinolin-2-one
  147. 4j21: Tankyrase 2 in Complex with 7-(4-amino-2-chlorophenyl)-4- Methylquinolin-2(1h)-one
  148. 4j22: Tankyrase 2 in Complex with 3-chloro-4-(4-methyl-2-oxo-1,2- Dihydroquinolin-7-yl)-n-[2-(morpholin-4-yl)ethyl]benzamide
  149. 4j3l: Tankyrase 2 in Complex with 3-chloro-n-(2-methoxyethyl)-4-(4-methyl-2- Oxo-1,2-dihydroquinolin-7-yl)benzamide
  150. 4j3m: Tankyrase 2 in Complex with 3-chloro-4-(4-methyl-2-oxo-1,2- Dihydroquinolin-7-yl)benzoic Acid
  151. 6f5f: Structure of Artd2/parp2 Wgr Domain Bound to Double Strand Dna with 5 Nucleotide Overhang and 5'phosphate
  152. 6f5b: Structure of Artd2/parp2 Wgr Domain Bound to Double Stranded Dna with 5'phosphate
  153. 3w51: Tankyrase in Complex with 2-hydroxy-4-methylquinoline
  154. 6f1k: Structure of Artd2/parp2 Wgr Domain Bound to Double Strand Dna without 5'phosphate
  155. 4j1z: Tankyrase 2 in Complex with 4-chloro-1,2-dihydrophatalzin-one
  156. 6ek3: Parp15 Catalytic Domain Mutant (Y598L) in Complex with Oul35
  157. 4l6s: Parp Complexed with Benzo[1,4]oxazin-3-one Inhibitor
  158. 6cf6: Rnf146 Tbm-tankyrase Arc2-3 Complex
  159. 4bj9: Crystal Structure of Human Tankyrase 2 in Complex with Eb-47
  160. 4bjb: Crystal Structure of Human Tankyrase 2 in Complex with Pj-34
  161. 4bjc: Crystal Structure of Human Tankyrase 2 in Complex with Rucaparib
  162. 4bs4: Crystal Structure of Human Tankyrase 2 in Complex with 4'-isopropylflavone
  163. 4bu3: Crystal Structure of Human Tankyrase 2 in Complex with 2-phenyl-3,4-dihydroquinazolin-4-one
  164. 4bu5: Crystal Structure of Human Tankyrase 2 in Complex with 2-(4- Hydroxyphenyl)-3,4-dihydroquinazolin-4-one
  165. 4bu6: Crystal Structure of Human Tankyrase 2 in Complex with 2-(4- Aminophenyl)-3,4-dihydroquinazolin-4-one
  166. 4bu7: Crystal Structure of Human Tankyrase 2 in Complex with 2-(4- Bromophenyl)-3,4-dihydroquinazolin-4-one
  167. 4bu8: Crystal Structure of Human Tankyrase 2 in Complex with 4-(4- Oxo-1,4-dihydroquinazolin-2-yl)benzonitrile
  168. 4bu9: Crystal Structure of Human Tankyrase 2 in Complex with 2-(4- Methoxyphenyl)-3,4-dihydroquinazolin-4-one
  169. 4bua: Crystal Structure of Human Tankyrase 2 in Complex with 2-(4- (methylsulfanyl)phenyl)-3,4-dihydroquinazolin-4-one
  170. 4bud: Crystal Structure of Human Tankyrase 2 in Complex with 2-(4- Tert-butylphenyl)-1,4-dihydroquinazolin-4-one
  171. 4bue: Crystal Structure of Human Tankyrase 2 in Complex with 3-methyl- N-(4-(4-oxo-3,4-dihydroquinazolin-2-yl)phenyl)butanamide
  172. 4buf: Crystal Structure of Human Tankyrase 2 in Complex with 2-(4- Acetylphenyl)-3,4-dihydroquinazolin-4-one
  173. 4bui: Crystal Structure of Human Tankyrase 2 in Complex with Methyl 4-(4-oxo-3,4-dihydroquinazolin-2-yl)benzoate
  174. 4bus: Crystal Structure of Human Tankyrase 2 in Complex with 2-(4- (4-oxo-3,4-dihydroquinazolin-2-yl)phenoxy)acetic Acid
  175. 4but: Crystal Structure of Human Tankyrase 2 in Complex with 4-(4- Oxo-3,4-dihydroquinazolin-2-yl)benzene-1-sulfonamide
  176. 4buu: Crystal Structure of Human Tankyrase 2 in Complex with (4- (4-oxo-3,4-dihydroquinazolin-2-yl)phenyl)methanesulfonamide
  177. 4buv: Crystal Structure of Human Tankyrase 2 in Complex with N-(4- (4-oxo-3,4-dihydroquinazolin-2-yl)phenyl)thiophene-2-carboxamide
  178. 4buw: Crystal Structure of Human Tankyrase 2 in Complex with 2-(4- (2-oxo-1,3-oxazolidin-3-yl)phenyl)-3,4- Dihydroquinazolin-4-one
  179. 4bux: Crystal Structure of Human Tankyrase 2 in Complex with 3-(( 4-(4-oxo-3,4-dihydroquinazolin-2-yl)phenyl)methyl) Imidazolidine-2,4-dione
  180. 4buy: Crystal Structure of Human Tankyrase 2 in Complex with 5- Methyl-5-(4-(4-oxo-3,4-dihydroquinazolin-2-yl)phenyl) Imidazolidine-2,4-dione
  181. 4krs: Tankyrase-1 Complexed with Small Molecule Inhibitor
  182. 4kzl: Crystal Structure of Human Tankyrase 2 in Complex with 4'-fluoro Flavone
  183. 4kzq: Crystal Structure of Human Tankyrase 2 in Complex with 4' -hydroxy Flavone
  184. 4kzu: Crystal Structure of Human Tankyrase 2 in Complex with 4' -bromo Flavone
  185. 4l09: Crystal Structure of Human Tankyrase 2 in Complex with 4-(4-oxo-4h- Chromen-2-yl)benzoic Acid
  186. 4l0b: Tankyrase 2 in Complex with 4'-dimethylamino Flavone
  187. 4l0i: Tankyrase 2 Catalytic Domain in Complex with Ethyl 4-(4-oxo-4h- Chromen-2-yl)benzoate
  188. 4l0s: Tankyrase 2 in Complex with 4'-cyano Flavone
  189. 4l0t: Tankyrase 2 in Complex with 4'-nitro Flavone
  190. 4l0v: Tankyrase 2 in Complex with 4'-chloro Flavone
  191. 4l10: Tankyrase 2 in Complex with 4'-methoxy Flavone
  192. 4l2f: Tankyrase 2 in Complex with 6-chloro Flavone
  193. 4l2g: Tankyrase 2 in Complex with 6- Fluoro Flavone
  194. 4l2k: Tankyrase 2 in Complex with 2-(1,3-benzodioxol-5-yl)-4h-chromen-4-one
  195. 4l31: Tankyrase 2 in Complex with Methyl 4-(4-oxochromen-2-yl)benzoate
  196. 4l32: Tankyrase 2 in Complex with 2-[4-(4-methylpiperazine-1-carbonyl) Phenyl]chromen-4-one
  197. 4l33: Tankyrase 2 in Complex with Cyanomethyl 4-(4-oxo-4h-chromen-2-yl) Benzoate
  198. 4l34: Tankyrase 2 in Complex with 4'-tetrazole Flavone
  199. 4l6z: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Sto1168
  200. 4l70: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Me0352
  201. 4l7l: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Me0368
  202. 4l7n: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Sto1542
  203. 4l7o: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Sto1542
  204. 4l7p: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Me0395
  205. 4l7r: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Me0400
  206. 4l7u: Human Artd3 (parp3) - Catalytic Domain in Complex with Inhibitor Me0398
  207. 4li6: Tankyrase-1 Complexed with Small Molecule Inhibitor N-[(4-oxo-3,4- Dihydroquinazolin-2-yl)methyl]-3-phenyl-n-(thiophen-2-ylmethyl) Propanamide
  208. 4li7: Tankyrase-1 Complexed with Small Molecule Inhibitor 4-chloro-5-cyano- N-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-2-methoxybenzamide
  209. 4li8: Tankyrase-1 Complexed with Small Molecule Inhibitor 2-[4-(4- Fluorobenzoyl)piperidin-1-yl]-n-[(4-oxo-3,5,7,8-tetrahydro-4h- Pyrano[4,3-d]pyrimidin-2-yl)methyl]-n-(thiophen-2-ylmethyl)acetamide
  210. 4m7b: Human Tankyrase 2 - Catalytic Parp Domain in Complex with an Inhibitor Upf1854
  211. 4msg: Crystal Structure of Tankyrase 1 with Compound 22
  212. 4msk: Co-crystal Structure of Tankyrase 1 with Compound 34
  213. 4mt9: Co-crystal Structure of Tankyrase 1 with Compound 49
  214. 4n3r: Co-crystal Structure of Tankyrase 1 with Compound 2 (5-(2- Aminoquinazolin-6-yl)-n-(4,4-dimethyl-2-oxo-1,2,3,4- Tetrahydroquinolin-7-yl)-2-fluorobenzamide)
  215. 4n4t: Co-crystal Structure of Tankyrase 1 with Compound 3 [(4s)-3-{4-[6- Amino-5-(pyrimidin-2-yl)pyridin-3-yl]phenyl}-5,5-dimethyl-4-phenyl-1, 3-oxazolidin-2-one]
  216. 4n4v: Co-crystal Structure of Tankyrase 1 with Compound 4 [(4s)-3-{trans-4- [6-amino-5-(pyrimidin-2-yl)pyridin-3-yl]cyclohexyl}-5,5-dimethyl-4- Phenyl-1,3-oxazolidin-2-one]
  217. 4opx: Structure of Human Parp-1 Bound to a Dna Double Strand Break in Complex with (2r)-5-fluoro-2-methyl-2,3-dihydro-1-benzofuran-7- Carboxamide
  218. 4oqa: Structure of Human Parp-1 Bound to a Dna Double Strand Break in Complex with (2z)-2-(2,4-dihydroxybenzylidene)-3-oxo-2,3-dihydro-1- Benzofuran-7-carboxamide
  219. 4oqb: Structure of Human Parp-1 Bound to a Dna Double Strand Break in Complex with (2z)-2-{4-[2-(morpholin-4-yl)ethoxy]benzylidene}-3-oxo- 2,3-dihydro-1-benzofuran-7-carboxamide
  220. 4pjt: Structure of Parp1 Catalytic Domain Bound to Inhibitor Bmn 673
  221. 4pjv: Structure of Parp2 Catalytic Domain Bound to Inhibitor Bmn 673
  222. 4pml: Crystal Structure of Human Tankyrase 2 in Complex with 3-amino- Benzamide.
  223. 4pnl: Crystal Structure of Tnks-2 in Complex with Dr2313.
  224. 4pnm: Crystal Structure of Human Tankyrase 2 in Complex with Nu1025.
  225. 4pnn: Crystal Structure of Human Tankyrase 2 in Complex with 4hqn.
  226. 4pnq: Crystal Structure of Human Tankyrase 2 in Complex with 5aiq.
  227. 4pnr: Crystal Structure of Human Tankyrase 2 in Complex with Tiq-a.
  228. 4pns: Crystal Structure of Human Tankyrase 2 in Complex with INH2BP.
  229. 4pnt: Crystal Structure of Human Tankyrase 2 in Complex with 1,5-iqd.
  230. 5xsu: Novel Orally Efficacious Inhibitors Complexed with Parp1
  231. 5xst: Novel Orally Efficacious Inhibitors Complexed with Parp1
  232. 5xsr: Novel Orally Efficacious Inhibitors Complexed with Parp1
  233. 5wtc: Structure of Human Parp1 Catalytic Domain Bound to a Quinazoline-2, 4(1h,3h)-dione Inhibitor
  234. 5ws1: Structure of Human Parp1 Catalytic Domain Bound to a Benzoimidazole Inhibitor
  235. 5ws0: Structure of Human Parp1 Catalytic Domain Bound to a Benzoimidazole Inhibitor
  236. 5wrz: Structure of Human Parp1 Catalytic Domain Bound to a Phthalazinone Inhibitor
  237. 5wry: Structure of Human Parp1 Catalytic Domain Bound to a Quinazoline-2, 4(1h,3h)-dione Inhibitor
  238. 5wrq: Structure of Human Parp1 Catalytic Domain Bound to a Quinazoline-2, 4(1h,3h)-dione Inhibitor
  239. 4tju: Crystal Structure of Human Tankyrase 2 in Complex with 3,4-cpq-5-c.
  240. 4tjw: Crystal Structure of Human Tankyrase 2 in Complex with Pj-34.
  241. 4tjy: Crystal Structure of Human Tankyrase 2 in Complex with Abt-888.
  242. 4tk0: Crystal Structure of Human Tankyrase 2 in Complex with Dpq.
  243. 4tk5: Crystal Structure of Human Tankyrase 2 in Complex with Eb47.
  244. 4tkf: Crystal Structure of Human Tankyrase 2 in Complex with Iwr-1.
  245. 4tkg: Crystal Structure of Human Tankyrase 2 in Complex with Azd2281.
  246. 4tki: Crystal Structure of Human Tankyrase 2 in Complex with Bsi-201.
  247. 5v7w: Crystal Structure of Human Parp14 Bound to 2-{[(1-methylpiperidin-4- Yl)methyl]amino}-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin- 4(3h)-one Inhibitor
  248. 5v7t: Crystal Structure of Parp14 Bound to N-{4-[4-(diphenylmethoxy) Piperidin-1-yl]butyl}[1,2,4]triazolo[4,3-b]pyridazin-6-amine Inhibitor
  249. 5qia: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000242A
  250. 5qi8: Pandda Analysis Group Deposition -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000605A
  251. 5qi7: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000506A
  252. 5qi5: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000633A
  253. 5qi4: Pandda Analysis Group Deposition -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000466A
  254. 5qi3: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000475A
  255. 5qi2: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000110A
  256. 5qi1: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000474A
  257. 5qi0: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000352A
  258. 5qhz: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000385A
  259. 5qhy: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000462A
  260. 5qhx: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000278A
  261. 5qhw: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000347A
  262. 5qhv: Pandda Analysis Group Deposition -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000299A
  263. 5qhu: Pandda Analysis Group Deposition of Models with Modelled Events (e.g. Bound Ligands) -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMSOA000341B
  264. 5qht: Pandda Analysis Group Deposition -- Crystal Structure of Human Parp14 Macrodomain 3 in Complex with FMOPL000065A
  265. 5owt: Crystal Structure of Tnks2 in Complex with (5s)-5-methyl-5-[4-(4-oxo- 3,4-dihydroquinazolin-2-yl)phenyl]imidazolidine-2,4-dione
  266. 5ows: Crystal Structure of Tnks2 in Complex with 2-[4-(4-methyl-2- Oxoimidazolidin-4-yl)phenyl]-3,4-dihydroquinazolin-4-one
  267. 5o2d: Parp14 Macrodomain 2 with Inhibitor
  268. 5nxe: Crystal Structure of Tnks2 in Complex with 2-{4-[(2-hydroxyethyl) (methyl)amino]phenyl}-1,2,3,4-tetrahydroquinazolin-4-one
  269. 5nwg: Crystal Structure of Tnks2 in Complex with 7-chloro-2-{4-[(2- Hydroxyethyl)(methyl)amino]phenyl}-3,4-dihydroquinazolin-4-one
  270. 5nwd: Crystal Structure of Tnks2 in Complex with 2-[4-(diethylamino)phenyl]- 3,4-dihydroquinazolin-4-one
  271. 5nwc: Crystal Structure of Tnks2 in Complex with 2-(2-aminophenyl)-3,4- Dihydroquinazolin-4-one
  272. 5nwb: Crystal Structure of Tnks2 in Complex with 2-{4-[(2-hydroxyethyl) (methyl)amino]phenyl}-3,4-dihydroquinazolin-4-one
  273. 5nvh: Crystal Structure of Tnks2 in Complex with 2-[4-(piperidin-1-yl) Phenyl]-3,4-dihydroquinazolin-4-one
  274. 5nvf: Crystal Structure of Tnks2 in Complex with 2-[4-(pyridin-2-yl)phenyl]- 3,4-dihydroquinazolin-4-one
  275. 5nve: Crystal Structure of Tnks2 in Complex with 2-(4-ethoxyphenyl)-3,4- Dihydroquinazolin-4-one
  276. 5nvc: Crystal Structure of Tnks2 in Complex with 2-(3-hydroxyphenyl)-3,4- Dihydroquinazolin-4-one
  277. 5nut: Crystal Structure of Tnks2 in Complex with 2-[4-(propan-2-yloxy) Phenyl]-3,4-dihydroquinazolin-4-one
  278. 5nt4: Crystal Structure of Tnks2 in Complex with 2-[4-(morpholin-4-yl) Phenyl]-3,4-dihydroquinazolin-4-one
  279. 5nt0: Crystal Structure of Tnks2 in Complex with 2-(3-aminophenyl)-3,4- Dihydroquinazolin-4-one
  280. 5nsx: Crystal Structure of Tnks2 in Complex with 2-(1h-indazol-5-yl)-3,4- Dihydroquinazolin-4-one
  281. 5nsp: Crystal Structure of Tnks2 in Complex with Od334
  282. 5nqe: Human Parp14 (artd8), Catalytic Fragment in Complex with an N-aryl Piperazine Inhibitor
  283. 5nob: Crystal Structure of Human Tankyrase 2 in Complex with Od336
  284. 5lyh: Human Parp14 (artd8), Catalytic Fragment in Complex with Inhibitor H10
  285. 5lxp: Human Parp14 (artd8), Catalytic Fragment in Complex with Inhibitor H5
  286. 5lx6: Human Parp10 (artd10), Catalytic Fragment in Complex with Parp Inhibitor Veliparib
  287. 5kpq: Structure of Human Parp1 Catalytic Domain Bound to a Quinazoline-2, 4(1h,3h)-dione Inhibitor
  288. 5kpp: Structure of Human Parp1 Catalytic Domain Bound to a Quinazoline-2, 4(1h,3h)-dione Inhibitor
  289. 5kpo: Structure of Human Parp1 Catalytic Domain Bound to a Quinazoline-2, 4(1h,3h)-dione Inhibitor
  290. 5kpn: Structure of Human Parp1 Catalytic Domain Bound to a Quinazoline-2, 4(1h,3h)-dione Inhibitor
  291. 5kni: Crystal Structure of The Wild-type Sam Domain of Human Tankyrase-1
  292. 5ju5: Crystal Structure of The Human Tankyrase 1 (tnks) Sam Domain (D1055R), Crystal Form 1
  293. 5jti: Crystal Structure of The Human Tankyrase 1 (tnks) Sam Domain (D1055R), Crystal Form 2
  294. 5jrt: Crystal Structure of The Human Tankyrase 2 (tnks2) Sam Domain (dh902/924re)
  295. 5jhq: Arcs 1-3 of Human Tankyrase-1 Bound to a Peptide Derived from Irap
  296. 5hkp: Crystal Structure of Mouse Tankyrase/human Trf1 Complex
  297. 5ha9: Crystal Structure-based Design and Disovery of a Novel Parp1 Antiagonist (bl-pa10) That Induces Apoptosis and Inhibits Metastasis in Triple Negative Breast Cancer
  298. 5gp7: Structural Basis for The Binding between Tankyrase-1 and Usp25
  299. 5ety: Crystal Structure of Human Tankyrase-1 Bound to K-756
  300. 5ece: Tankyrase 1 with Phthalazinone 1
  301. 5ebt: Tankyrase 1 with Phthalazinone 2
  302. 5dzq: C3LARVIN Toxin, an Adp-ribosyltransferase from Paenibacillus Larvae, Orthorhombic Form
  303. 5dsy: Crystal Structure of Constitutively Active Parp-2
  304. 5ds3: Crystal Structure of Constitutively Active Parp-1
  305. 5dcz: Tankyrase 2 Complexed with a Selective Inhibitor
  306. 5d5k: Crystal Structure Nls from Human Parp-2 Complexed with Importin Alpha Delta Ibb
  307. 5c5r: Crystal Structure of Human Tankyrase-2 in Complex with a Pyranopyridone Inhibitor
  308. 5c5q: Crystal Structure of Human Tankyrase-2 in Complex with a Pyranopyridone Inhibitor
  309. 5c5p: Crystal Structure of Human Tankyrase-2 in Complex with a Pyranopyridone Inhibitor
  310. 5bxu: Human Tankyrase-2 in Complex with Macrocyclised Extended Peptide CP4N4M5
  311. 5bxo: Human Tankyrase-2 in Complex with Macrocyclised Extended Peptide CP4N2M3
  312. 4oa7: Crystal Structure of Tankyrase1 in Complex with Iwr1
  313. 5al5: Crystal Structure of Tnks2 in Complex with 2-(4-((pyridin-4- Yl)methyl)piperazin-1-yl)-3,4,5,6,7,8-hexahydroquinazolin-4-one
  314. 5al4: Crystal Structure of Tnks2 in Complex with 2-(4- Methylpiperazin-1-yl)-3,4,5,6,7,8-hexahydroquinazolin-4-one
  315. 5al3: Crystal Structure of Tnks2 in Complex with 2-(2,4- Dichlorophenyl)-1-methyl-1h,2h,3h,4h-pyrido(2,3-d) Pyrimidin-4-one
  316. 5al2: Crystal Structure of Tnks2 in Complex with 2-(4-(propan-2- Yl)phenyl)-1h,2h,3h,4h-pyrido(2,3-d)pyrimidin-4-one
  317. 5al1: Crystal Structure of Tnks2 in Complex with 2-(4-tert- Butylphenyl)-1h,2h,3h,4h-pyrido(2,3-d)pyrimidin-4-one
  318. 5akw: Crystal Structure of Tnks2 in Complex with 2-(4- Chlorophenyl)-1,2,3,4-tetrahydroquinazolin-4-one
  319. 5aku: Crystal Structure of Tnks2 in Complex with 2-(4-tert- Butylphenyl)-1,2,3,4-tetrahydroquinazolin-4-one
  320. 5aeh: Crystal Structure of Human Tankyrase 2 in Complex with Od332
  321. 5a3c: Crystal Structure of The Adp-ribosylating Sirtuin (sirtm) from Streptococcus Pyogenes in Complex with Nad
  322. 5a3b: Crystal Structure of The Adp-ribosylating Sirtuin (sirtm) from Streptococcus Pyogenes in Complex with Adp-ribose
  323. 5a3a: Crystal Structure of The Adp-ribosylating Sirtuin (sirtm) from Streptococcus Pyogenes (apo Form)
  324. 5a00: Structure of Human Parp1 Catalytic Domain Bound to an Isoindolinone Inhibitor
  325. 4zzz: Structure of Human Parp1 Catalytic Domain Bound to an Isoindolinone Inhibitor
  326. 4zzy: Structure of Human Parp2 Catalytic Domain Bound to an Isoindolinone Inhibitor
  327. 4zzx: Structure of Parp2 Catalytic Domain Bound to an Isoindolinone Inhibitor
  328. 4z9c: Ecpltab Oxidized
  329. 4z68: Hybrid Structural Analysis of The Arp2/3 Regulator Arpin Identifies Its Acidic Tail as a Primary Binding Epitope
  330. 4py4: Crystal Structure of Human Poly(adp-ribose) Polymerase 14, Catalytic Domain in Complex with an Inhibitor Xl2
  331. 4tor: Crystal Structure of Tankyrase 1 with Iwr-8
  332. 4tos: Crystal Structure of Tankyrase 1 with 355
  333. 4w5s: Tankyrase in Complex with Compound
  334. 4w6e: Human Tankyrase 1 with Small Molecule Inhibitor
  335. 2n8a: 1h, 13c and 15n Chemical Shift Assignments and Solution Structure for Parp-1 F1F2 Domains in Complex with a Dna Single-strand Break
  336. 4r5w: Human Artd1 (parp1) - Catalytic Domain in Complex with Inhibitor Xav939
  337. 4r6e: Human Artd1 (parp1) - Catalytic Domain in Complex with Inhibitor Niraparib
  338. 4rv6: Human Artd1 (parp1) Catalytic Domain in Complex with Inhibitor Rucaparib
  339. 4tvj: Human Artd2 (parp2) - Catalytic Domain in Complex with Olaparib
  340. 4u6a: X-ray Crystal Structure of Human Tnks in Complex with a Small Molecule Inhibitor
  341. 4ufu: Crystal Structure of Human Tankyrase 2 in Complex with Ta-12
  342. 4ufy: Crystal Structure of Human Tankyrase 2 in Complex with Ta-13
  343. 4uhg: Crystal Structure of Human Tankyrase 2 in Complex with Ta-21
  344. 4ui3: Crystal Structure of Human Tankyrase 2 in Complex with Ta-26
  345. 4ui4: Crystal Structure of Human Tankyrase 2 in Complex with Ta-29
  346. 4ui5: Crystal Structure of Human Tankyrase 2 in Complex with Ta-41
  347. 4ui6: Crystal Structure of Human Tankyrase 2 in Complex with Ta-47
  348. 4ui7: Crystal Structure of Human Tankyrase 2 in Complex with Ta-49
  349. 4ui8: Crystal Structure of Human Tankyrase 2 in Complex with Ta-55
  350. 4und: Human Artd1 (parp1) - Catalytic Domain in Complex with Inhibitor Talazoparib
  351. 4uuh: X-ray Crystal Structure of Human Tnks in Complex with a Small Molecule Inhibitor
  352. 4uvl: Crystal Structure of Human Tankyrase 2 in Complex with 5-amino-1,2- Dihydroisoquinolin-1-one
  353. 4uvn: Crystal Structure of Human Tankyrase 2 in Complex with 5-amino-3-(4- Chlorophenyl)-1,2-dihydroisoquinolin-1-one
  354. 4uvo: Crystal Structure of Human Tankyrase 2 in Complex with 5-amino-3-(4- Methoxyphenyl)-1,2-dihydroisoquinolin-1-one
  355. 4uvs: Crystal Structure of Human Tankyrase 2 in Complex with 5-amino-3- Pentyl-1,2-dihydroisoquinolin-1-one
  356. 4uvt: Crystal Structure of Human Tankyrase 2 in Complex with 5-amino-4- Methyl-1,2-dihydroisoquinolin-1-one
  357. 4uvu: Crystal Structure of Human Tankyrase 2 in Complex with 1-((4-(5- Methyl-1-oxo-1,2-dihydroisoquinolin-3-yl)phenyl)methyl)pyrrolidin-1- Ium
  358. 4uvv: Crystal Structure of Human Tankyrase 2 in Complex with 3-(4- Chlorophenyl)-5-methyl-1,2-dihydroisoquinolin-1-one
  359. 4uvw: Crystal Structure of Human Tankyrase 2 in Complex with 4,5-dimethyl-3- Phenyl-1,2-dihydroisoquinolin-1-one
  360. 4uvx: Crystal Structure of Human Tankyrase 2 in Complex with 3-(4- Chlorophenyl)-5-fluoro-1,2-dihydroisoquinolin-1-one
  361. 4uvy: Crystal Structure of Human Tankyrase 2 in Complex with 3-(4- Chlorophenyl)-5-methoxy-1,2- Dihydroisoquinolin-1-one
  362. 4uvz: Crystal Structure of Human Tankyrase 2 in Complex with 5-amino-3- Phenyl-1,2-dihydroisoquinolin-1-one
  363. 4uw1: X-ray Crystal Structure of Human Tnks in Complex with a Small Molecule Inhibitor
  364. 4ux4: Crystal Structure of Human Tankyrase 2 in Complex with 1-methyl-7-(4- Methylphenyl)-5-oxo-5,6-dihydro-1,6-naphthyridin-1-ium
  365. 4uxb: Human Artd1 (parp1) - Catalytic Domain in Complex with Inhibitor Pj34
  366. 4w5i: Crystal Structure of Human Tankyrase 2 in Complex with 1-methyl-7- Phenyl-1,2,3,4,5,6-hexahydro-1,6- Naphthyridin-5-one
  367. 4xhu: The Complex Structure of Timeless_pab and Parp-1_catalytic Domain
  368. 7aaa: Crystal Structure of The Catalytic Domain of Human Parp1 (apo)
  369. 7aab: Crystal Structure of The Catalytic Domain of Human Parp1 in Complex with Inhibitor Eb-47
  370. 7aac: Crystal Structure of The Catalytic Domain of Human Parp1 in Complex with Veliparib
  371. 7aad: Crystal Structure of The Catalytic Domain of Human Parp1 in Complex with Olaparib
  372. 7kk2: Structure of The Catalytic Domain of Parp1
  373. 7kk3: Structure of The Catalytic Domain of Parp1 in Complex with Talazoparib
  374. 7kk4: Structure of The Catalytic Domain of Parp1 in Complex with Olaparib
  375. 7kk5: Structure of The Catalytic Domain of Parp1 in Complex with Niraparib
  376. 7kk6: Structure of The Catalytic Domain of Parp1 in Complex with Veliparib
© Copyright 2008-2009 by enzymes.me.uk